The second is Foundayo (orforglipron), a daily, non-peptide GLP-1 pill from Eli Lilly that was FDA-approved in April 2026 and is now available in the UAE through licensed pharmacies
So is it giving like a timeout to the digestive system
Proper sterile technique prevents most infections, but vigilance catches problems early
Per effetti sistemici (collagene, infiammazione, stress ossidativo), le iniezioni sottocutanee addominali sono le pi pratiche
Presented for research literature review only Joshi UM et al
[2] Semaglutide works through several complementary mechanisms: it stimulates insulin secretion from the pancreas when blood glucose levels are elevated, suppresses the release of glucagon (a hormone that raises blood sugar), slows gastric emptying to reduce post-meal glucose spikes, and acts on appetite centres in the brain to promote satiety and reduce food intake